Retinoid X receptor α attenuates host antiviral response by suppressing type I interferon

Nature Communications

Volumn 5, Issue , 2014, Pages

  Ma, Feng ^a   Liu, Su Yang ^a   Razani, Bahram ^a   Arora, Neda ^a   Li, Bing ^b   Kagechika, Hiroyuki ^c   Tontonoz, Peter ^a,d   Núñez, Vanessa ^e   Ricote, Mercedes ^e   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; INTERFERON; LIGAND; MESSENGER RNA; RETINOID X RECEPTOR AGONIST; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VIRUS RNA; VITAMIN D; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; AGN 194204; BETA CATENIN; BETA INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; SMALL INTERFERING RNA; TETRALIN DERIVATIVE; UNSATURATED FATTY ACID;

ANTIMICROBIAL ACTIVITY; CYTOLOGY; GENE EXPRESSION; LIGAND; RISK ASSESSMENT; VIRAL DISEASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA VIRUS; GAMMAHERPESVIRINAE; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; INFECTION RISK; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA VIRUS; VESICULOVIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; ACTIVE TRANSPORT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DOWN REGULATION; GENETICS; HEK293 CELL LINE; HERPES SIMPLEX; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; RNA INTERFERENCE; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL PLAQUE ASSAY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BETA CATENIN; CELL LINE; DOWN-REGULATION; FATTY ACIDS, UNSATURATED; HEK293 CELLS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INTERFERON-BETA; LIGANDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; RETINOID X RECEPTOR ALPHA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRAHYDRONAPHTHALENES; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL PLAQUE ASSAY;

EID: 84922165128     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6494     Document Type: Article

References (53)

1. Repa, J. J. et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529 (2000).
2. Kastner, P. et al. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78, 987-1003 (1994).
3. Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R. & Gronemeyer, H. RAR and RXR modulation in cancer and metabolic disease. Nat. Rev. Drug Discov. 6, 793-810 (2007).
4. Nagy, L., Szanto, A., Szatmari, I. & Szeles, L. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol. Rev. 92, 739-789 (2012).
5. Mangelsdorf, D. J. & Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83, 841-850 (1995).
6. Lefebvre, P., Benomar, Y. & Staels, B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol. Metab. 21, 676-683 (2010).
7. Dawson, M. I. & Xia, Z. The retinoid X receptors and their ligands. Biochim. Biophys. Acta 1821, 21-56 (2012).
8. Mangelsdorf, D. J. et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6, 329-344 (1992).
9. Rowe, A., Eager, N. S. & Brickell, P. M. A member of the RXR nuclear receptor family is expressed in neural-crest-derived cells of the developing chick peripheral nervous system. Development 111, 771-778 (1991).
10. Yu, V. C. et al. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67, 1251-1266 (1991).
11. Roszer, T., Menendez-Gutierrez, M. P., Cedenilla, M. & Ricote, M. Retinoid X receptors in macrophage biology. Trends Endocrinol. Metab. 24, 460-468 (2013).
12. Ricote, M. et al. Normal hematopoiesis after conditional targeting of RXRalpha in murine hematopoietic stem/progenitor cells. J. Leukoc. Biol. 80, 850-861 (2006).
13. Nunez, V. et al. Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression. Proc. Natl Acad. Sci. USA 107, 10626-10631 (2010).
14. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. & Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345, 224-229 (1990).
15. Perez, E., Bourguet, W., Gronemeyer, H. & de Lera, A. R. Modulation of RXR function through ligand design. Biochim. Biophys. Acta 1821, 57-69 (2012).
16. Kempf, W., Kettelhack, N., Duvic, M. & Burg, G. Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol. Oncol. Clin. North Am. 17, 1405-1419 (2003).
17. Zhang, C. & Duvic, M. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol. Ther. 16, 322-330 (2003).
18. Chow, E. K. et al. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. J. Exp. Med. 203, 2589-2602 (2006).
19. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. & Tontonoz, P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219 (2003).
20. Na, S. Y. et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J. Biol. Chem. 274, 7674-7680 (1999).
21. Wang, X., Allen, C. & Ballow, M. Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPSstimulated monocytes/macrophages. J. Clin. Immunol. 27, 193-200 (2007).
22. Joseph, S. B. et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299-309 (2004).
23. Liu, P. T. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773 (2006).
24. Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75-86 (2009).
25. Goubau, D., Deddouche, S. & Reis, E. S. C. Cytosolic sensing of viruses. Immunity 38, 855-869 (2013).
26. Newton, K. & Dixit, V. M. Signaling in innate immunity and inflammation. Cold Spring Harbor perspectives in biology 4, a006049 (2012).
27. Sadler, A. J. & Williams, B. R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568 (2008).
28. Rathinam, V. A., Sharma, S. & Fitzgerald, K. A. Catenin' on to nucleic acid sensing. Nat. Immunol. 11, 466-468 (2010).
29. Yang, P. et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol. 11, 487-494 (2010).
30. Zhu, J., Coyne, C. B. & Sarkar, S. N. PKC alpha regulates Sendai virusmediated interferon induction through HDAC6 and beta-catenin. EMBO J. 30, 4838-4849 (2011).
31. Gantner, B. N. et al. The Akt1 isoform is required for optimal IFN-beta transcription through direct phosphorylation of beta-catenin. J. Immunol. 189, 3104-3111 (2012).
32. Choi, S. J. et al. Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J. Biol. Chem. 281, 30669-30677 (2006).
33. Rochette-Egly, C. & Chambon, P. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Histol. Histopathol. 16, 909-922 (2001).
34. Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D. & Chambon, P. RXRalphanull F9 embryonal carcinoma cells are resistant to the differentiation, antiproliferative and apoptotic effects of retinoids. EMBO J. 15, 4142-4155 (1996).
35. Ebisawa, M. et al. Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem. Pharm. Bull. (Tokyo). 47, 1778-1786 (1999).
36. Negrete, O. A. et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436, 401-405 (2005).
37. Berg, W. J. et al. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferonalpha- 2a. Clin. Cancer Res. 5, 1671-1675 (1999).
38. Tsimberidou, A. M., Giles, F., Romaguera, J., Duvic, M. & Kurzrock, R. Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies. Cancer 100, 574-580 (2004).
39. Recchia, F. et al. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. Anticancer Res. 25, 3149-3157 (2005).
40. Baxter, K. F. & Cunliffe, W. J. Retinoid herpeticum. Clin. Exp. Dermatol. 26, 557-558 (2001).
41. Stetson, C. L., Butler, D. F. & Rapini, R. P. Herpetic whitlow during isotretinoin therapy. Int. J. Dermatol. 42, 496-498 (2003).
42. Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H. & Moon, R. T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680-685 (2003).
43. Beattie, L. et al. A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Host Microbe 14, 357-368 (2013).
44. Xiao, J. H. et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J. Biol. Chem. 278, 29954-29962 (2003).
45. Chin, A. I. et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-194 (2002).
46. Palleroni, A. V., Varesio, L., Wright, R. B. & Brunda, M. J. Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int. J. Cancer 49, 296-302 (1991).
47. Zhou, H., Imrich, A. & Kobzik, L. Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines. Part. Fibre Toxicol. 5, 7 (2008).
48. Doyle, S. et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263 (2002).
49. Liu, S. Y., Sanchez, D. J., Aliyari, R., Lu, S. & Cheng, G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl Acad. Sci. USA 109, 4239-4244 (2012).
50. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008).
51. Ma, F. et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 184, 6053-6059 (2010).
52. Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat. Immunol. 12, 861-869 (2011).
53. Mokrani, H., Sharaf el Dein, O., Mansuroglu, Z. & Bonnefoy, E. Binding of YY1 to the proximal region of the murine beta interferon promoter is essential to allow CBP recruitment and K8H4/K14H3 acetylation on the promoter region after virus infection. Mol. Cell Biol. 26, 8551-8561 (2006).